MOTS-C vs SLU-PP-332

MOTS-C

MOTS-c (Mitochondrial Open Reading Frame of the Twelve S rRNA type-c) is a 16-amino acid peptide encoded within the mitochondrial genome, specifically within the 12S rRNA gene. Its primary mechanism of action involves activation of the AMPK pathway, which regulates cellular energy homeostasis by promoting glucose uptake and fatty acid oxidation independent of insulin signaling. Research published by Lee et al. (Cell Metabolism, 2015) demonstrated that MOTS-c use in diet-induced obese mice significantly improved glucose tolerance and reduced fat accumulation without altering food intake. Subsequent studies from the same USC laboratory showed that MOTS-c levels decline with age in human plasma, and that exercise increases circulating MOTS-c levels, suggesting it functions as a mitochondrial-derived exercise mimetic. Unlike traditional metabolic peptides that target specific membrane receptors, MOTS-c is unique in that it translocates to the nucleus under metabolic stress to regulate nuclear gene expression, particularly genes involved in the methionine-folate cycle and de novo purine biosynthesis. Compared to other mitochondrial-derived peptides like humanin, MOTS-c appears more specifically involved in metabolic regulation rather than cytoprotection. The lyophilized peptide should be stored at -20C and protected from light; reconstitute with bacteriostatic water and store reconstituted solutions at 2-8C for up to 21 days. MOTS-c is primarily researched by aging biology laboratories, exercise physiology departments, and mitochondrial medicine research centers investigating metabolic signaling peptides.

SLU-PP-332

SLU-PP-332 is a synthetic small-molecule agonist of estrogen-related receptors (ERRs), specifically ERR-alpha, ERR-beta, and ERR-gamma. These orphan nuclear receptors regulate the transcription of genes involved in mitochondrial biogenesis, oxidative phosphorylation, and fatty acid metabolism. Research from the Bhatt laboratory at Saint Louis University (published in ACS Chemical Biology, 2023) demonstrated that SLU-PP-332 use in mouse models increased exercise endurance and fatigue resistance without physical training, earning it attention as a potential exercise mimetic compound. The mechanism involves upregulating PGC-1alpha-dependent gene networks that modulate mitochondrial density and oxidative capacity in skeletal muscle. In ischemic stroke models, ERR activation by SLU-PP-332 has shown neuroprotective effects by preserving mitochondrial membrane integrity and reducing reactive oxygen species production (Willy et al., published in Cell Chemical Biology). Compared to other exercise mimetics such as AICAR (AMPK activator) or GW501516 (PPAR-delta agonist), SLU-PP-332 targets a distinct upstream transcriptional pathway that coordinately activates multiple metabolic gene programs rather than a single signaling cascade. Research also suggests potential applications in chronic fatigue and neurodegenerative conditions where mitochondrial dysfunction is implicated. Store lyophilized powder at -20C in a desiccated environment; reconstitute in DMSO or appropriate vehicle per study specifications. SLU-PP-332 is investigated by exercise physiology researchers, neuroscience departments studying metabolic neuroprotection, and pharmacology labs exploring nuclear receptor biology.

Frequently Asked Questions